Department of Medicine

Genetic ancestry and hypertension risk

Racial disparities in hypertension risk are due in part to genetic differences between ancestries, Vanderbilt investigators find in a study of participants in the Million Veteran Program.

VUMC team screens high school for SARS-CoV-2 asymptomatic infections

Under the SARS CoV-2 Return to School Saliva Opt-in Screening Study, which began last November at University School of Nashville, a research team from Vanderbilt University Medical Center is testing a solution for efficient asymptomatic disease surveillance and control.

The study team includes, from left, Douglas Heimburger, MD, MS, Kondwelani Mateyo, MBChB, MMed, Justin Banerdt, MD, MPH, and E. Wesley Ely, MD.

Vanderbilt, Zambia researchers identify predictive factors of delirium in Sub-Saharan Africa

Severity of illness, history of stroke, and being divorced or widowed were independently predictive of delirium in hospitalized patients in Zambia, according to a study published in PLOS ONE.

Zheng named VICC associate director for Population Sciences Research

Wei Zheng, MD, PhD, MPH, Anne Potter Wilson Professor of Medicine, has been named associate director for Population Sciences Research at Vanderbilt- Ingram Cancer Center (VICC).

New Clinician Spotlight: Jason Springer

Jason Springer, MD, MS, has joined Vanderbilt University Medical Center as associate professor of Medicine in the Division of Rheumatology and Immunology in the Department of Medicine. Springer is co-director of the Vanderbilt Vasculitis Center, where he will oversee vasculitis clinical trials.

New therapeutic strategy for leukemia syndrome

Using primary cells from patients with chronic myelomonocytic leukemia, Vanderbilt researchers found synergistic inhibition of cell viability and proliferation, suggesting a new treatment strategy.

1 57 58 59 60 61 125